Ind. Code § 25-1-9.5-8
This is the official text of Ind. Code § 25-1-9.5-8, part of Indiana’s Code — part of the compiled statutory law of Indiana, published by the state as "Code." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Issuance of prescription; controlled substance conditions
Official statutory text
Sec. 8. (a) A prescriber may issue a prescription to a patient who is receiving services through the use of telehealth if the patient has not been examined previously by the prescriber in person if the following conditions are met:
(1) The prescriber has satisfied the applicable standard of care in the treatment of the patient.
(2) The issuance of the prescription by the prescriber is within the prescriber's scope of practice and certification.
(3) The prescription:
(A) meets the requirements of subsection (b); and
(B) is not for an opioid. However, an opioid may be prescribed if the opioid:
(i) has been approved by the federal Food and Drug Administration for the treatment of opioid addiction; and
(ii) is used to treat or manage opioid dependence.
(4) The prescription is not for an abortion inducing drug (as defined in IC 16-18-2-1.6).
(5) If the prescription is for a medical device, including an ophthalmic device, the prescriber must use telehealth technology that is sufficient to allow the provider to make an informed diagnosis and treatment plan that includes the medical device being prescribed. However, a prescription for an ophthalmic device is also subject to the conditions in section 13 of this chapter.
(b) Except as provided in subsection (a), a prescriber may issue a prescription for a controlled substance (as defined in IC 35-48-1.1-7) to a patient who is receiving services through the use of telehealth, even if the patient has not been examined previously by the prescriber in person, if the following conditions are met:
(1) The prescriber maintains a valid controlled substance registration under IC 35-48-3.
(2) The prescriber meets the conditions set forth in 21 U.S.C. 829 et seq., 21 CFR 1300, 1304, and 1306, and any other regulation enforced by the federal Drug Enforcement Agency.
(3) A practitioner acting in the usual course of the practitioner's professional practices issues the prescription for a legitimate medical purpose.
(4) The telehealth communication is conducted using an audiovisual, real time, two-way interactive communication system.
(5) The prescriber complies with the requirements of the INSPECT program (IC 25-26-24).
(6) All other applicable federal and state laws are followed.
(c) A prescription for a controlled substance under this section must be prescribed and dispensed in accordance with IC 25-1-9.3 and IC 25-26-24.
As added by P.L.78-2016, SEC.2. Amended by P.L.150-2017, SEC.7; P.L.51-2019, SEC.3; P.L.28-2019, SEC.10; P.L.211-2019, SEC.34; P.L.52-2020, SEC.4; P.L.85-2021, SEC.18; P.L.143-2025, SEC.44; P.L.186-2025, SEC.137.
(1) The prescriber has satisfied the applicable standard of care in the treatment of the patient.
(2) The issuance of the prescription by the prescriber is within the prescriber's scope of practice and certification.
(3) The prescription:
(A) meets the requirements of subsection (b); and
(B) is not for an opioid. However, an opioid may be prescribed if the opioid:
(i) has been approved by the federal Food and Drug Administration for the treatment of opioid addiction; and
(ii) is used to treat or manage opioid dependence.
(4) The prescription is not for an abortion inducing drug (as defined in IC 16-18-2-1.6).
(5) If the prescription is for a medical device, including an ophthalmic device, the prescriber must use telehealth technology that is sufficient to allow the provider to make an informed diagnosis and treatment plan that includes the medical device being prescribed. However, a prescription for an ophthalmic device is also subject to the conditions in section 13 of this chapter.
(b) Except as provided in subsection (a), a prescriber may issue a prescription for a controlled substance (as defined in IC 35-48-1.1-7) to a patient who is receiving services through the use of telehealth, even if the patient has not been examined previously by the prescriber in person, if the following conditions are met:
(1) The prescriber maintains a valid controlled substance registration under IC 35-48-3.
(2) The prescriber meets the conditions set forth in 21 U.S.C. 829 et seq., 21 CFR 1300, 1304, and 1306, and any other regulation enforced by the federal Drug Enforcement Agency.
(3) A practitioner acting in the usual course of the practitioner's professional practices issues the prescription for a legitimate medical purpose.
(4) The telehealth communication is conducted using an audiovisual, real time, two-way interactive communication system.
(5) The prescriber complies with the requirements of the INSPECT program (IC 25-26-24).
(6) All other applicable federal and state laws are followed.
(c) A prescription for a controlled substance under this section must be prescribed and dispensed in accordance with IC 25-1-9.3 and IC 25-26-24.
As added by P.L.78-2016, SEC.2. Amended by P.L.150-2017, SEC.7; P.L.51-2019, SEC.3; P.L.28-2019, SEC.10; P.L.211-2019, SEC.34; P.L.52-2020, SEC.4; P.L.85-2021, SEC.18; P.L.143-2025, SEC.44; P.L.186-2025, SEC.137.
Status: in_force · Read it on the official government site
Need a lawyer in Indiana?
Find a Indiana lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.